Does DAPAGLIFLOZIN Cause Decreased appetite? 284 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 284 reports of Decreased appetite have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 1.3% of all adverse event reports for DAPAGLIFLOZIN.
284
Reports of Decreased appetite with DAPAGLIFLOZIN
1.3%
of all DAPAGLIFLOZIN reports
27
Deaths
159
Hospitalizations
How Dangerous Is Decreased appetite From DAPAGLIFLOZIN?
Of the 284 reports, 27 (9.5%) resulted in death, 159 (56.0%) required hospitalization, and 42 (14.8%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 284 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN Cause?
Death (2,775)
Diabetic ketoacidosis (1,773)
Acute kidney injury (982)
Off label use (891)
Nausea (884)
Dehydration (860)
Vomiting (838)
Dizziness (817)
Ketoacidosis (803)
Fatigue (785)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which DAPAGLIFLOZIN Alternatives Have Lower Decreased appetite Risk?
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN vs DAPRODUSTAT
DAPAGLIFLOZIN vs DAPSONE
DAPAGLIFLOZIN vs DAPTOMYCIN